WhiteBook2_Part2 - 42

Appendix
Develop new capacities to
reduce burden
Improve performance of existing
capacities to reduce burden
Improve performance of existing
capacities to reduce burden
Prevention and
control
Drug therapy
Health care
quality, access,
and evaluation
Swiss society of Gastroenterology
Improve performance of existing
capacities to reduce burden
Health care
quality, access,
and evaluation
Turkish Society of Gastroenterology
Assess burden of disease and its
determinants
Assess burden of disease and its
determinants
Develop new capacities to
reduce burden
Develop new capacities to
reduce burden
Improve performance of existing
capacities to reduce burden
Epidemiology
Pathology and
physiopathology
Diagnosis
Diagnosis
Complications
Ukrainian Gastroenterological Association
Improve performance of existing
capacities to reduce burden
Improve performance of existing
capacities to reduce burden
Improve performance of existing
capacities to reduce burden
Improve performance of existing
capacities to reduce burden
Improve performance of existing
capacities to reduce burden
VVGE and SRBGE (Belgium)
Develop new capacities to
reduce burden
Develop new capacities to
reduce burden
Develop new capacities to
reduce burden
Develop new capacities to
reduce burden
Improve performance of existing
capacities to reduce burden
Diagnosis
Drug therapy
Drug therapy
Pathology and
physiopathology
Complications
Other diseases of liver (K71K77)
Crohn's
disease and
ulcerative colitis (K50-K51)
Malignant neoplasms of
digestive organs (C15-C26)
Irritable bowel syndrome
(K58)
Other diseases of liver (K71K77)
Development
and
implementation of precision
medicine
new treatments, nutrition and
extraintestinal manifestations
Personalised treatments in
digestive oncology
Development of
neurogastroenterology
improving outcome in NASH,
liver transplantation, ...
Diet therapy
Drug therapy
Drug therapy
Microbiology
Prevention and
control
All diseases of the digestive
system (K20-K93)
Irritable bowel syndrome
(K58)
Other diseases of liver (K71K77)
Crohn's
disease and
ulcerative colitis (K50-K51)
All diseases of the digestive
system (K20-K93)
Nutrition should have more
impact in prevention/
treatment
IBS dominated in practice and
hasn't effective treatment
High prevalence of NAFLD and
limited treatment's options
Microbiome - one of most
important targets for
interventions
Absence of prevention strategy
in European gastroenterology
Not applicable
expert opinion statements,
structure of training
Crohn's disease and
ulcerative colitis (K50-K51)
Diseases of pancreas (K85K86,
K87.1)
Diseases of oesophagus
(K20-K23)
Malignant neoplasms of
digestive organs (C15-C26)
Diseases of pancreas (K85K86,
K87.1)
Epidemiological study National
IBD prevalence and incidence
Pancreatic steatosis and
metabolic syndrome
HRM, different catheters,
normal and cut off values
Colorectal carcinoma screening
programmes
Acute pancreatitis:
epidemiology, clinic and
management
Other diseases of liver (K71K77)
Crohn's
disease and
ulcerative colitis (K50-K51)
Crohn's disease and
ulcerative colitis (K50-K51)
-
-
-
White Book 2: Part 2
39
WhiteBook2_Part2

Table of Contents for the Digital Edition of WhiteBook2_Part2
